Active Ingredient: LIDOCAINE; TETRACAINE
Proprietary Name: PLIAGLIS
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 7%;7%
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021717
Product Number: 001
Approval Date: Jun 29, 2006
Applicant Holder Full Name: CRESCITA THERAPEUTICS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
